Damian Garde

Damian Garde
Damian Garde

Damian Garde, Editor

Damian is an editor with Fierce's life sciences publications, writing for FierceBiotech, FierceMedicalDevices and FierceCRO. Prior to joining Fierce, he worked for Patch.com in Maryland, and The Albuquerque Journal and Weekly Alibi in Albuquerque, NM. Damian lives in Washington, DC, and considers himself the foremost Carmelo Anthony apologist in the greater metropolitan area. You can email him at [email protected] and follow @DamianFierce on Twitter.

Stories by Damian Garde

Alnylam pockets $7M from Genzyme as RNAi program hums along

Gene-silencing expert Alnylam is $7 million richer thanks to some positive mid-stage results for its Genzyme-licensed RNA-interference candidate, and the Cambridge, MA, company is looking to be the first to market with the difficult-to-deliver class of treatments.

Fresenius cans managers tied to data manipulation

Fresenius Kabi is taking seriously the FDA's allegations that staff at an Indian API plant lied to investigators and concealed data, and the generic drug unit of the German healthcare giant said it has fired the workers responsible.

Oramed raising $4.6M for oral insulin trial

Fresh off the launch of a Phase IIa trial for its oral insulin pill, Oramed has inked a deal with investors to sell $4.6 million worth of shares, cash the company will use to complete the study and push its compound toward commercialization.